SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-021465
Filing Date
2023-03-20
Accepted
2023-03-20 17:17:09
Documents
72
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0123_enzobiochem.htm   iXBRL 10-Q 1188003
2 CERTIFICATION f10q0123ex31-1_enzobio.htm EX-31.1 9375
3 CERTIFICATION f10q0123ex31-2_enzobio.htm EX-31.2 9522
4 CERTIFICATION f10q0123ex32-1_enzobio.htm EX-32.1 3748
5 CERTIFICATION f10q0123ex32-2_enzobio.htm EX-32.2 3965
  Complete submission text file 0001213900-23-021465.txt   6589210

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20230131.xsd EX-101.SCH 62980
7 XBRL CALCULATION FILE enz-20230131_cal.xml EX-101.CAL 44206
8 XBRL DEFINITION FILE enz-20230131_def.xml EX-101.DEF 224345
9 XBRL LABEL FILE enz-20230131_lab.xml EX-101.LAB 507859
10 XBRL PRESENTATION FILE enz-20230131_pre.xml EX-101.PRE 239431
66 EXTRACTED XBRL INSTANCE DOCUMENT f10q0123_enzobiochem_htm.xml XML 1268557
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 23747138
SIC: 8071 Services-Medical Laboratories